Recent developments of the antimitotic agentsNAM, Nguyen-Hai.Current pharmaceutical design. 2005, Vol 11, Num 13, issn 1381-6128, 142 p.Serial Issue

Recent developments in the chemical biology of epothilonesALTMANN, Karl-Heinz.Current pharmaceutical design. 2005, Vol 11, Num 13, pp 1595-1613, issn 1381-6128, 19 p.Article

Pharmaceutical design of antimitotic agents based on combretastatinsHSIEH, H. P; LIOU, J. P; MAHINDROO, N et al.Current pharmaceutical design. 2005, Vol 11, Num 13, pp 1655-1677, issn 1381-6128, 23 p.Article

Improving the targeting of tubulin-binding agents : Lessons from drug resistance studiesVERRILLS, N. M; KAVALLARIS, M.Current pharmaceutical design. 2005, Vol 11, Num 13, pp 1719-1733, issn 1381-6128, 15 p.Article

The chemistry and biology of antimitotic chalcones and related enone systemsLAWRENCE, Nicholas J; MCGOWN, Alan T.Current pharmaceutical design. 2005, Vol 11, Num 13, pp 1679-1693, issn 1381-6128, 15 p.Article

The epothilones and related analogues-A review of their syntheses and anti-cancer activitiesWATKINS, E. Blake; CHITTIBOYINA, Amar G; JUNG, Jae-Chul et al.Current pharmaceutical design. 2005, Vol 11, Num 13, pp 1615-1653, issn 1381-6128, 39 p.Article

Podophyllotoxin derivatives : Current synthetic approaches for new anticancer agentsYOU, Youngjae.Current pharmaceutical design. 2005, Vol 11, Num 13, pp 1695-1717, issn 1381-6128, 23 p.Article